Acumen Pharmaceuticals, Inc.
SEC CIK 1576885 · ABOS · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Porter Derrell | Director | filed 2023–2026 |
| Fountain Nathan B | Director | filed 2021–2026 |
| RA Capital Healthcare Fund LP | Director | filed 2021–2026 |
| Drapkin Kimberlee C | Director | filed 2022–2026 |
| RA Capital Management, LLC | Director | filed 2021–2026 |
| Kolchinsky Peter | Director | filed 2021–2026 |
| Golumbeski George | Director | filed 2025–2026 |
| Ives Jeffrey L. | Director | filed 2021–2026 |
| Shah Rajeev M. | Director | filed 2021–2026 |
| Stalfort Sean | Director | filed 2021–2026 |
| RA Capital Nexus Fund II, L.P. | Director | filed 2021–2026 |
| Stoppel Laura | Director | filed 2021–2026 |
| Oconnell Daniel Joseph | Director · President and CEO | filed 2021–2026 |
| Sevigny Jeffrey | Director | filed 2021–2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Meisner Derek M | Chief Legal Officer & Corp Sec | filed 2022–2026 |
| Zuga Matt | Chief Financial Officer | filed 2021–2026 |
| Siemers Eric | Chief Medical Officer | filed 2021–2026 |
| Barton Russell | Chief Operating Officer | filed 2021–2026 |
| Doherty James J. | President and CDO | filed 2024–2026 |
| Schacterle Amy | Chief Regulatory Officer | filed 2024–2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.